King International Investment (HKSE:00928) Debt-to-Equity : 0.03 (As of Sep. 2023)

View and export this data going back to 2002. Start your Free Trial

What is King International Investment Debt-to-Equity?

King International Investment's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was HK$4.3 Mil. King International Investment's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2023 was HK$1.5 Mil. King International Investment's Total Stockholders Equity for the quarter that ended in Sep. 2023 was HK$237.5 Mil. King International Investment's debt to equity for the quarter that ended in Sep. 2023 was 0.02.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for King International Investment's Debt-to-Equity or its related term are showing as below:

HKSE:00928' s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.01 Max: 0.59
Current: 0.03

During the past 13 years, the highest Debt-to-Equity Ratio of King International Investment was 0.59. The lowest was 0.00. And the median was 0.01.

HKSE:00928's Debt-to-Equity is ranked better than
90.26% of 195 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.22 vs HKSE:00928: 0.03

King International Investment Debt-to-Equity Historical Data

The historical data trend for King International Investment's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

King International Investment Debt-to-Equity Chart

King International Investment Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Debt-to-Equity

Get a 7-Day Free Trial

0.01

0.03

King International Investment Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Debt-to-Equity	Get a 7-Day Free Trial															-	-	0.02	0.03	0.03

Competitive Comparison of King International Investment's Debt-to-Equity

For the Diagnostics & Research subindustry, King International Investment's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

King International Investment's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, King International Investment's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where King International Investment's Debt-to-Equity falls into.

King International Investment Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

King International Investment's Debt to Equity Ratio for the fiscal year that ended in Mar. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4.265	+	2.462)	/	237.505
	=	0.03

King International Investment's Debt to Equity Ratio for the quarter that ended in Sep. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4.307	+	1.548)	/	237.507
	=	0.02

King International Investment (HKSE:00928) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

King International Investment Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of King International Investment's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

King International Investment (HKSE:00928) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » King International Investment Ltd (HKSE:00928) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

18 Harbour Road, Room 6307-08, 63rd Floor, Central Plaza, Wanchai, Hong Kong, HKG

Website

https://www.lifehealthcare.com

King International Investment Ltd formerly Life Healthcare Group Ltd is an investment holding company. The company's operating segment includes the Healthcare products and services business and Money lending business. It generates maximum revenue from the Healthcare products and services business segment. Geographically, it derives a majority of revenue from PRC. The group is primarily a provider of genetic testing and health data analysis services.

King International Investment (HKSE:00928) Headlines

No Headlines